Dökmetaş, M., Muğlu, H., Özcan, E., Kuvvet, B. B., Helvacı, K., Kalacı, E., . . . Bilici, A. (2025). Endocrine Adverse Events in Patients Treated with Immune Checkpoint Inhibitors. Medicina, 61(1), 123. https://doi.org/10.3390/medicina61010123
Chicago-referens (17:e uppl.)Dökmetaş, Meriç, et al. "Endocrine Adverse Events in Patients Treated with Immune Checkpoint Inhibitors." Medicina 61, no. 1 (2025): 123. https://doi.org/10.3390/medicina61010123.
MLA-referens (9:e uppl.)Dökmetaş, Meriç, et al. "Endocrine Adverse Events in Patients Treated with Immune Checkpoint Inhibitors." Medicina, vol. 61, no. 1, 2025, p. 123, https://doi.org/10.3390/medicina61010123.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.
